Trial intelligence / Profile preview

Oral versus vaginal misoprostol for labor induction

PACTR202208496861650Recruiting

Sponsor
Metagen Therapeutics, Inc.
Start
Sep 2022
Modality
Small Molecules
Countries
1
01

Overview

Open-label trial of misoprostol in pregnancy, sponsored by Metagen Therapeutics, Inc. Primary endpoint: Effectiveness of misoprostol in inducing uterine contractions. Started Sep 2022; status: recruiting.

02

Drugs

misoprostol
03

Conditions

pregnancy

Beyond the preview

Go deeper on PACTR202208496861650.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on PACTR202208496861650.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call